SCHEMBL6740474

SCHEMBL6740474

[CH2]Cc1cc(C#N)cc([N+](=O)[O-])c1

nearest known ligand 0.67

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
VCAM1 P19320 4/20 0.67
KCNJ1 P48048 2/20 0.40
KCNH2 Q12809 2/20 0.40
XDH P47989 1/20 0.38
CYP19A1 P11511 1/20 0.36
GRIN2D O15399 1/20 0.36
GRIN3B O60391 1/20 0.36
GRIN1 Q05586 1/20 0.36
GRIN2A Q12879 1/20 0.36
GRIN2B Q13224 1/20 0.36
GRIN2C Q14957 1/20 0.36
GRIN3A Q8TCU5 1/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
TLR9 Q9NR96 1/20 0.35
TSHR P16473 2/20 0.35
RAD51 Q06609 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5897979 0.84 VCAM1 (0.69) VCAM1KCNJ1KCNH2XDHCYP19A1
SCHEMBL248953 0.83 VCAM1 (0.67) VCAM1KCNJ1KCNH2XDHCYP19A1
SCHEMBL5897983 0.83 VCAM1 (0.67) VCAM1KCNJ1KCNH2XDHCYP19A1
SCHEMBL7090977 0.81 VCAM1 (0.91) VCAM1XDHCYP19A1GRIN2DGRIN3B
SCHEMBL1005421 0.81 VCAM1 (1.00) VCAM1XDHCYP19A1GRIN2DGRIN3B
SCHEMBL6403631 0.81 CYP19A1 (0.54) VCAM1CYP19A1MEN1KMT2ATSHR
SCHEMBL28048148 0.80 VCAM1 (0.62) VCAM1KCNJ1KCNH2XDHCYP19A1
SCHEMBL250131 0.79 VCAM1 (0.61) VCAM1KCNJ1KCNH2XDHTSHR
SCHEMBL20647048 0.78 VCAM1 (0.59) VCAM1KCNJ1KCNH2MEN1KMT2A
SCHEMBL16953139 0.77 VCAM1 (0.74) VCAM1KCNJ1KCNH2XDHCYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6689771-B2 TREATMENT OF RHEUMATOID ARTHRITIS, OSTEOARTHRITIS, PERIODONTITIS, GINGIVITIS, CORNEAL ULCERATION, SOLID TUMOR GROWTH BRISTOL-MYERS SQUIBB PHARMA COMPANY 2004-02-10 US disclosed
US-6376665-B1 ANTIARTHRITIC AGENTS, ANTIINFLAMMATORY AGENTS BRISTOL-MYERS SQUIBB PHARMA COMPANY 2002-04-23 US disclosed
EP-1165500-A1 AMIDE DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES,TNF-ALPHA,AND AGGRECANASE Du Pont Pharmaceuticals Company (US) 2002-01-02 EP disclosed
WO-2000059874-A1 NOVEL AMIDE DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES, TNF-α, AND AGGRECANASE DU PONT PHARMACEUTICALS COMPANY (US) 2000-10-12 WO disclosed